SalivaDirect, Inc

Pandemic response efforts require nimble, dynamic thinking and a willingness to innovate. By embracing this mindset and championing a dynamic, collaborative response, SalivaDirect helped communities overcome challenges of the COVID-19 pandemic. What began with the development of an open-source, low-cost COVID-19 diagnostic assay at Yale School of Public Health has grown into a Global Diagnostic Network and a spinout into a new, independent nonprofit: SalivaDirect, Inc. SalivaDirect Inc, the nonprofit, is continuing to propel the use of saliva as a superior sample type for accessible, equitable surveillance of respiratory pathogens. To date, more than 200 CLIA laboratories have provided over...

Research,pandemic response,and equitable diagnostic testing

Salivadirect, inc operates in the Biotechnology research industry.

Salivadirect, inc's revenue is 11m - 100m

Salivadirect, inc has 11 - 50 employees.